Allene M. Diaz, Director at IONIS PHARMACEUTICALS INC (IONS), sold 1,637 shares at $50.17 ($81K) on 2024-07-16, disclosed to the SEC on 2024-07-17.
Scheduled sale ($81k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.94 | 900 | $44K | 54.4% |
| 2 | $50.17 | 737 | $37K | 45.6% |
| Total | $49.49 avg | 1,637 | $81K | 100% |
| Filing → |
| IONS | SELL | 2025-08-26 | $121K | — | Filing → |
| IONS | SELL | 2023-08-03 | $27K | — | Filing → |